Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
暂无分享，去创建一个
D. Berry | M. Ellis | E. Winer | C. Hudis | P. Friedman | D. Cowan | L. Dressler | L. Harris | A. Thor | D. Hayes | G. Broadwater | C. Cirrincione | D. Budman | M. Abu-Khalaf